Serum total 8-iso-prostaglandin F 2α: A new and independent predictor of peripheral arterial disease

Journal of Vascular Surgery

Volumn 40, Issue 4, 2004, Pages 768-773

  Mueller, T ^a   Dieplinger, B ^a   Gegenhuber, A ^b   Haidinger, D ^b   Schmid, N ^a   Roth, N ^a   Ebner, F ^b   Landl, M ^b   Poelz, W ^c   Haltmayer, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Internal Medicine ^*  (Austria)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CREATININE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN F2 ALPHA; TRIACYLGLYCEROL;

AGE; AGED; ARTERY DISEASE; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; ENZYME IMMUNOASSAY; FEMALE; GENDER; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSTAGLANDIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SMOKING;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 4744352054     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.07.044     Document Type: Article

References (18)

1. J.I. Weitz, J. Byrne, G.P. Clagett, M.E. Farkouh, J.M. Porter, D.L Sackett Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review Circulation 94 1996 3026 3049
2. M.H. Criqui, J.O. Denenberg, R.D. Langer, A. Fronek The epidemiology of peripheral arterial disease: importance of identifying the population at risk Vasc Med 2 1997 221 226
3. G.J. Blake, P.M. Ridker Inflammatory bio-markers and cardiovascular risk prediction J Intern Med 252 2002 283 294
4. D. Harrison, K.K. Griendling, U. Landmesser, B. Hornig, H. Drexler Role of oxidative stress in atherosclerosis Am J Cardiol 91 2003 7A 11A
5. J.D. Morrow The isoprostanes: their quantification as an index of oxidant stress status in vivo Drug Metab Rev 32 2000 377 385
6. 2-isoprostanes) are formed in situ on phospholipids Proc Natl Acad Sci U S A 89 1992 10721 10725
7. 2-isoprostane) metabolites in human urine and plasma J Biol Chem 268 1993 4161 4169
8. C. Patrono, G.A. FitzGerald Isoprostanes: potential markers of oxidant stress in atherothrombotic disease Arterioscler Thromb Vasc Biol 17 1997 2309 2315
9. L.J. Roberts, J.D. Morrow Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo Free Radic Biol Med 28 2000 505 513
10. E. Schwedhelm, R.H. Boger Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease Clin Chem Lab Med 41 2003 1552 1561
11. C. Vassalle, N. Botto, M.G. Andreassi, S. Berti, A. Biagini Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease Coronary Artery Dis 14 2003 213 218
12. M.K. Sinha, D.C. Gaze, J.R. Tippins, P.O. Collinson, J.C. Kaski Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention Circulation 107 2003 2403 2405
13. 2α as a risk marker in patients with coronary heart disease: a matched case-control study Circulation 109 2004 843 848
14. 2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E Circulation 106 2002 2543 2549
15. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, S Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
16. D. Sacks, C.W. Bakal, P.T. Beatty, G.J. Becker, J.F. Cardella, R.D Raabe Position statement on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease J Vasc Interv Radiol 14 suppl 2003 389
17. E.G. Grant, C.B. Benson, G.L. Moneta, A.V. Alexandrov, J.D. Baker, E.I Bluth Carotid artery stenosis: gray-scale and Doppler US diagnosis. Society of Radiologists in Ultrasound Consensus Conference Radiology 229 2003 340 346
18. 2- isoprostanes) in smokers: smoking as a cause of oxidative damage N Engl J Med 332 1995 1198 1203